| 标题 |
A phase 1b/2 study of first-line anti-PD-L1/ TGF-βRII fusion protein SHR-1701 combined with nab-paclitaxel and gemcitabine for advanced pancreatic ductal adenocarcinoma |
| 网址 | |
| DOI | |
| 其它 |
期刊:Signal Transduction and Targeted Therapy 作者:Ran Xue; Miao-Yan Wei; Jia-Jia Yuan; Zhi-Hua Li; Yuhong Zhou; et al 出版日期:2025-12-01 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)